Lupin Ltd Seeks Shareholder Nod for Deloitte as New Auditors

Lupin Limited has proposed appointing Deloitte Haskins & Sells Chartered Accountants LLP as its new statutory auditors for a five-year term.
This strategic shift will see Deloitte replace the incumbent BSR & Co. LLP, whose term concludes after the 2026 Annual General Meeting.

Reader Takeaway: Auditor transition signals governance focus; shareholder nod is key next step.

What just happened (today’s filing)

The Board of Directors of Lupin Limited has recommended the appointment of Deloitte Haskins & Sells Chartered Accountants LLP as the company's new statutory auditors.
This proposed term spans five consecutive years, commencing after the conclusion of the company's Forty-Fourth Annual General Meeting (AGM).
Deloitte Haskins & Sells, constituted in 1997 and converted to an LLP in 2021, will replace the current auditors, BSR & Co. LLP.
The appointment is contingent upon the approval of Lupin's shareholders at the upcoming AGM.

Why this matters

Appointing a new auditor is crucial for maintaining robust corporate governance and ensuring independent financial oversight.
This change can bring a fresh perspective to the company's financial reporting and compliance processes, reinforcing investor confidence.

Peer comparison

Among Lupin's peers, Dr. Reddy's Laboratories Ltd also uses Deloitte Haskins & Sells LLP as its statutory auditor.
Sun Pharmaceutical Industries Ltd, another major player, is audited by S.R. Batliboi & Co. LLP, an EY affiliate.

What changes now

Lupin's board has initiated the process to appoint Deloitte Haskins & Sells as its statutory auditor.
Shareholders will cast their vote on this proposal at the forthcoming Annual General Meeting.
The transition means BSR & Co. LLP will conclude its tenure with Lupin upon the completion of required approvals and formalities.

Context metrics (time-bound)

• Proposed Auditor Tenure: 5 years (FY27–FY31 estimated).
• Current Auditor Term End: Post-2026 AGM (FY27).
• New Auditor LLP Conversion Date: 2021 (FY21).

What to track next

• The outcome of the shareholder vote at the upcoming Annual General Meeting.
• The smooth execution of the transition from BSR & Co. LLP to Deloitte.
• Deloitte's initial audit reports and any key observations for Lupin.